Global Mechanical Thrombectomy Devices Market By Type (Stroke, Deep Vein Thrombosis (DVT), Pulmonary Embolism (PE)), By Application (Hospitals, ASCs), By Region, And Segment Forecasts, 2023 to 2038

The Global Mechanical Thrombectomy Devices Market was valued at USD 1.3 billion in 2023 and is projected to reach USD 3.9 billion by 2030, registering a CAGR of 16.4% during the forecast period of 2023-2030. The market's growth is driven by the rising cardiovascular disease prevalence, technological advances in medical devices and minimally invasive procedures. Mechanical thrombectomy devices play an important role in acute ischemic strokes and other vascular conditions as they can have a dramatic impact on patient outcomes.

Drivers:

Rising Incidence of Cardiovascular Diseases, Technological Advancements, and Demand for Minimally Invasive Procedures

• Cardiovascular Disease Prevalence: Cardiovascular diseases are on the rise across the globe which include stroke and peripheral artery disease are augmenting growth in the global mechanical thrombectomy devices market. Such devices are essential to treat acutely ischemic strokes in emergency settings.

• Technological Innovations: Advancements in medical technology, with the introduction of improved and safer next-generation thrombectomy devices, help propel the market growth.

• Minimally Invasive Procedures: The increasing inclination toward minimally invasive procedures by both patients and health care practitioners is also propelling the adoption of mechanical thrombectomy devices. They generally provide faster recovery and fewer complications compared with standard surgical operations.

Restraints:

High Costs and Lack of Skilled Professionals

• High Treatment Costs: The high cost of mechanical thrombectomy procedures and devices is a major barrier, especially in developing regions with poor health budgets.

• Skilled Professionals: The inability to find a trained healthcare professional able to perform mechanical thrombectomy procedures, especially in low-resource settings is likely going to hamper market growth.

Opportunity:

Emerging Markets, Increasing Healthcare Expenditure, and Telemedicine Integration

• Emerging Markets: The growing number of untapped patients in emerging markets represent untapped growth potential. The projected increase in healthcare expenditure and the continuous improvement of healthcare systems in these lands boost the demand for mechanical thrombectomy devices.

• Healthcare Expenditure: The increasing healthcare expenditure of these countries, as well as the commitment of their governments to more advanced stroke care infrastructure, will open new opportunities for market growth.

• Telemedicine Integration: Telemedicine’s adoption within stroke care will increase the success rates of patient treatment and the geographical spread of mechanical thrombectomy operations, particularly in less accessible areas. 

Market by Product Type Insights:

Stent Retrievers and Aspiration Thrombectomy Devices Dominate the Market

• Stent Retrievers: In 2023  the market share of stent retrievers was more than 50%, this segment was the most revenue-generating. Stent retrievers are the most frequently used clot-retrieval instrument with the highest achievement.

• Aspiration Thrombectomy Devices: Their increasing popularity is based on the effectiveness and user-friendliness of aspiration thrombectomy devices, and suction tools employed to remove clots. 

Market by End-use Insights:

Hospitals Lead the Market

• Hospitals: In 2023, this segment contained the highest market share, accounting for more than 60%. Hospitals are the most prevalent place of mechanical thrombectomy operations because they have the required infrastructure and practitioners.

Market by Regional Insights:

North America Holds the Largest Market Share

• North America: The biggest market share was held by North America. North America held 40% of the market in 2023. The presence of advanced healthcare infrastructure, an elevated incidence of cardiovascular diseases, and substantial investments in medical technology drive the growth of the region.

Competitive Scenario:

Major players in the Global Mechanical Thrombectomy Devices Market include Medtronic plc, Stryker Corporation, Penumbra, Inc., Terumo Corporation, Johnson & Johnson, Boston Scientific Corporation, Edwards Lifesciences Corporation, AngioDynamics, Inc., Inari Medical, Inc., and Teleflex Incorporated.

Scope of Work – Global Mechanical Thrombectomy Devices Market Report Metric Details

Key Market Developments:

• September 2022-Vesalio won the European CE Mark for its NeVa Net thrombectomy device that came with an integrated clot microfiltration technology.

• September 2021-Abbott announced today its acquisition of a commercial-stage medical device company with a minimally invasive mechanical aspiration thrombectomy system for removing peripheral blood clots. 

• May 2020-Control Medical Technology announced the US Food and Drug Administration (FDA) clearance of its Aspire MAX 7 – 11F Mechanical Thrombectomy Platform. Aspire MAX 7 – 11F Mechanical Thrombectomy platform targeting peripheral vessels to remove blood clots

Market Segmentation:

• Based on Product Type:

• Stent Retrievers

• Aspiration Thrombectomy Devices

• Ultrasonic Thrombectomy Devices

• Mechanical Thrombectomy Devices

• Based on End Use:

• Hospitals

• Ambulatory Surgical Centers

• Specialty Clinics

• Based on Region:

• North America (U.S., Canada)

• Europe (Germany, France, UK, Rest of Europe)

• Asia-Pacific (China, Japan, India, Rest of Asia-Pacific)

• Latin America (Brazil, Mexico, Rest of Latin America)

• Middle East & Africa (South Africa, UAE, Rest of MEA)

Frequently Asked Questions:

Q. What is the current market size of the Global Mechanical Thrombectomy Devices Market? A. The global mechanical thrombectomy devices market size was estimated at USD 1.3 billion in 2023 and is expected to reach USD 3.9 billion by 2030, registering a CAGR of 16.4% during the forecast period of 2023-2030.

Q. What are the major growth drivers of the Global Mechanical Thrombectomy Devices Market? A. The growth of the Global Mechanical Thrombectomy Devices Market is mainly driven by the rising incidence of cardiovascular diseases, technological advancements, and the demand for minimally invasive procedures.

Q. Which region holds the largest market share in the Global Mechanical Thrombectomy Devices Market? A. North America accounted for more than 40% of the market share in 2023, driven by advanced healthcare infrastructure and high prevalence of cardiovascular diseases.

Q. Who are the key market players in the Global Mechanical Thrombectomy Devices Market? A. Key players include Medtronic plc, Stryker Corporation, Penumbra, Inc., Terumo Corporation, Johnson & Johnson, Boston Scientific Corporation, Edwards Lifesciences Corporation, AngioDynamics, Inc., Inari Medical, Inc., and Teleflex Incorporated.